title: Silencing of the rotavirus NSP4 protein decreases the incidence of biliary atresia in murine model.
abstract: Biliary atresia is a common disease in neonates which causes obstructive jaundice and progressive hepatic fibrosis. Our previous studies indicate that rotavirus infection is an initiator in the pathogenesis of experimental biliary atresia (BA) through the induction of increased nuclear factor-kappaB and abnormal activation of the osteopontin inflammation pathway. In the setting of rotavirus infection, rotavirus nonstructural protein 4 (NSP4) serves as an important immunogen, viral protein 7 (VP7) is necessary in rotavirus maturity and viral protein 4 (VP4) is a virulence determiner. The purpose of the current study is to clarify the roles of NSP4, VP7 and VP4 in the pathogenesis of experimental BA. Primary cultured extrahepatic biliary epithelia were infected with Rotavirus (mmu18006). Small interfering RNA targeting NSP4, VP7 or VP4 was transfected before rotavirus infection both in vitro and in vivo. We analyzed the incidence of BA, morphological change, morphogenesis of viral particles and viral mRNA and protein expression. The in vitro experiments showed NSP4 silencing decreased the levels of VP7 and VP4, reduced viral particles and decreased cytopathic effect. NSP4-positive cells had strongly positive expression of integrin subunit α2. Silencing of VP7 or VP4 partially decreased epithelial injury. Animal experiments indicated after NSP4 silencing, mouse pups had lower incidence of BA than after VP7 or VP4 silencing. However, 33.3% of VP4-silenced pups (N = 6) suffered BA and 50% of pups (N = 6) suffered biliary injury after VP7 silencing. Hepatic injury was decreased after NSP4 or VP4 silencing. Neither VP4 nor VP7 were detected in the biliary ducts after NSP4. All together, NSP4 silencing down-regulates VP7 and VP4, resulting in decreased incidence of BA.
authors.affiliation: Department of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. fengjiexiong@126.com
authors.forename: Jiexiong
authors.initials: J
authors.lastname: Feng
authors.forename: Jixin
authors.initials: J
authors.lastname: Yang
authors.forename: Shuaiyu
authors.initials: S
authors.lastname: Zheng
authors.forename: Yinrong
authors.initials: Y
authors.lastname: Qiu
authors.forename: Chengwei
authors.initials: C
authors.lastname: Chai
mesh_terms: D000818:Animals; D001652:Bile Ducts / Q000473:pathology / Q000648:ultrastructure / Q000821:virology; D001656:Biliary Atresia / Q000473:pathology* / Q000821:virology*; D002460:Cell Line; D003588:Cytopathogenic Effect, Viral; D004195:Disease Models, Animal; D004848:Epithelium / Q000473:pathology / Q000648:ultrastructure / Q000821:virology; D005455:Fluorescent Antibody Technique; D020868:Gene Silencing; D006023:Glycoproteins / Q000235:genetics*; D015994:Incidence; D039421:Integrin alpha2 / Q000378:metabolism; D051379:Mice; D034741:RNA, Small Interfering / Q000378:metabolism; D012401:Rotavirus / Q000378:metabolism* / Q000502:physiology / Q000648:ultrastructure; D014118:Toxins, Biological / Q000235:genetics*; D017361:Viral Nonstructural Proteins / Q000235:genetics*; D014779:Virus Replication
chemical_list: D006023:Glycoproteins; D039421:Integrin alpha2; C081369:NS28 protein, rotavirus; D034741:RNA, Small Interfering; D014118:Toxins, Biological; D017361:Viral Nonstructural Proteins